3.9 Article

Targeting the TREM1-positive myeloid microenvironment in glioblastoma

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack

Abhishek Guha et al.

Summary: Glioblastoma (GBM) is a malignant brain tumor characterized by treatment resistance due to cellular and molecular heterogeneity. Targeting HuR, a regulator of posttranscriptional RNA regulation, represents a plausible therapeutic strategy for attacking GBM.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Neurosciences

SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation

Rajeshwari Chellappan et al.

Summary: Glial activation with the production of pro-inflammatory mediators is driven by HuR, an RNA regulator that plays a critical role in regulating inflammatory cytokine production in glia. The development of a small molecule inhibitor, SRI-42127, which blocks HuR's translocation, has shown promising effects in suppressing the production of pro-inflammatory mediators and microglial activation, indicating the potential for treating neurological diseases driven by this activation.
Article Oncology

Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma

Emilie Le Rhun et al.

Summary: Myelosuppression during temozolomide chemoradiotherapy is associated with the survival of patients with newly diagnosed glioblastoma. Female patients experience more marrow toxicity than males. Lymphopenia is related to the overall survival of patients.

NEURO-ONCOLOGY (2022)

Article Oncology

Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors

Natalia Filippova et al.

Summary: The study developed a new class of inhibitors targeting HuR protein dimerization, successfully inhibiting cancer cell proliferation, inducing apoptosis, and reducing colony formation, while also inhibiting tumor growth in mouse models. The research highlights the importance of focusing on key attributes of HuR, such as cytoplasmic localization and multimerization, which contribute to cancer progression.

CANCER RESEARCH (2021)

Review Chemistry, Medicinal

Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates

Harbinder Singh et al.

Summary: There has been significant progress in the discovery of novel ligands and modulators of TREMs in the last five years that mainly revolved around the function of TREM molecules. A few peptides showed encouraging results to modulate the expression and activity of TREMs in preclinical studies, and these peptides are currently under clinical investigation. Based on the findings so far in several careful studies, we expect novel therapeutics in the near future which could have the ability to treat various disease conditions associated with TREM expression.

EXPERT OPINION ON THERAPEUTIC PATENTS (2021)

Article Biochemistry & Molecular Biology

Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade

Michael L. Dixon et al.

Summary: This study revealed the enrichment of Blimp1(+) Treg and T-FR cells in tumors, with higher tumoral T-FR signatures indicating increased risk of melanoma metastasis. Deletion of Blimp1 in Treg cells impaired suppressive activity and reprogrammed them into effector T-cells, mainly within tumor-infiltrating Treg population. This destabilization, paired with increased anti-tumor responses and reshaping of the tumor microenvironment, delayed tumor growth and improved response to anti-PD-1 blockade.

MOLECULAR CANCER (2021)

Article Multidisciplinary Sciences

Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma

Erik Jung et al.

Summary: The perivascular niche (PVN) and tumor microtubes (TMs) in glioblastoma have been found to play a role in tumor progression and resistance to therapies, with the potential for partial compensation between the two niches. Glioma cells in both the PVN and network integration environments show resistance to radio- and chemotherapy.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages

Natalia Ochocka et al.

Summary: The study reveals molecular heterogeneity among myeloid cells in naive and glioma-bearing brains in mice, as well as a gender-specific gene expression in glioma-activated microglia, which is also supported by bulk and scRNA-seq data from human diffuse gliomas.

NATURE COMMUNICATIONS (2021)

Editorial Material Oncology

Cold-inducible RNA-binding protein (CIRBP) as a biomarker to predict recurrence of brain metastases

Pakawat Chongsathidkiet et al.

NEURO-ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics

Zengpanpan Ye et al.

Summary: Research suggests that targeting infiltrating myeloid cells in the tumor microenvironment may offer a novel direction for immunotherapy in improving the prognosis of patients with Glioblastoma (GBM). These myeloid cells play a crucial role in regulating GBM progression and affecting therapeutic efficacy.

ONCOGENE (2021)

Review Immunology

Roles of Neutrophils in Glioma and Brain Metastases

Ya-Jui Lin et al.

Summary: This review discusses the role and importance of neutrophils in brain cancer, as well as the correlation between neutrophils and prognosis of glioma and brain metastases. It also explores the phenotypes and functions of tumor-associated neutrophils, and the effects of various treatments on neutrophils.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, Research & Experimental

Glioma stem cells and their roles within the hypoxic tumor microenvironment

Nathaniel H. Boyd et al.

Summary: Tumor microenvironments result from cellular alterations in cancer that promote unrestricted growth and angiogenesis, with hypoxia and acidic stress known to modulate therapeutic resistance. Understanding the interplay between tumor microenvironments and glioma stem cells is crucial for developing better treatment options for glioblastoma.

THERANOSTICS (2021)

Review Biochemistry & Molecular Biology

Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer

Yariswamy Manjunath et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Immunology

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma

Syreeta DeCordova et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Biology

A map of tumor-host interactions in glioma at single-cell resolution

Francesca Pia Caruso et al.

GIGASCIENCE (2020)

Article Oncology

Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells

Luis Augusto Aguirre et al.

ONCOIMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression

Patricia P. Yee et al.

NATURE COMMUNICATIONS (2020)

Article Medicine, Research & Experimental

Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis

Naomi-Liza Denning et al.

JCI INSIGHT (2020)

Article Immunology

TREM-1 multimerization is essential for its activation on monocytes and neutrophils

Kevin Carrasco et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

Neutrophils escort circulating tumour cells to enable cell cycle progression

Barbara Maria Szczerba et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Cyril Neftel et al.

Article Biochemistry & Molecular Biology

Fusion-mediated chromosomal instability promotes aneuploidy patterns that resemble human tumors

Lucile Delespaul et al.

ONCOGENE (2019)

Review Cell Biology

Myeloid cell heterogeneity in cancer: not a single cell alike

Mate Kiss et al.

CELLULAR IMMUNOLOGY (2018)

Article Biotechnology & Applied Microbiology

A map of gene expression in neutrophil-like cell lines

Esther Rincon et al.

BMC GENOMICS (2018)

Article Biochemistry & Molecular Biology

Hu antigen R (HuR) multimerization contributes to glioma disease progression

Natalia Filippova et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Review Medicine, Research & Experimental

Immune microenvironment of gliomas

Anna Gieryng et al.

LABORATORY INVESTIGATION (2017)

Review Pharmacology & Pharmacy

TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives

Alessandra Tammaro et al.

PHARMACOLOGY & THERAPEUTICS (2017)

Review Immunology

Neutrophils in Gliomas

Matteo Massara et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Oncology

Neutrophils Promote the Malignant Glioma Phenotype through S100A4

Ji Liang et al.

CLINICAL CANCER RESEARCH (2014)

Article Biochemistry & Molecular Biology

Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1)-mediated Bcl-2 Induction Prolongs Macrophage Survival

Zhihong Yuan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Medicine, Research & Experimental

Transepithelial migration of neutrophils into the lung requires TREM-1

Julia Klesney-Tait et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Multidisciplinary Sciences

Identification of a target RNA motif for RNA-binding protein HuR

IL de Silanes et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)